On August 7, 2017, Peter Payne resigned from his position as Chief Executive Officer of Artemis Therapeutics Inc., effective as of August 18, 2017. On August 9, 2017, the Board of Directors of the company appointed Brian Culley as Interim Chief Executive Officer. Brian Culley, 46, served as Mast Therapeutics Inc.’s Chief Executive Officer since February 2010 and member of its Board of Directors since December 2011, until Mast’s merger with Savara Inc. in April 2017.